ArticleEuropean heart journal2017

Subtype-specific promoter-driven action potential imaging for precise disease modelling and drug testing in hiPSC-derived cardiomyocytes.

Zhifen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.